Chronic migraine affects roughly 3.6 million Americans and is classified as one of the most disabling neurological conditions in the world, yet a significant portion of those who live with it have never found a preventive or abortive medication that reliably intercepts the attacks. The clinical picture is often one of partial relief — a triptan that works sometimes, a preventive that dulled the frequency but did not eliminate it, a preventive medication trial after medication trial without the kind of control that allows a person to live their life fully. At Tri-Cities Infusion and Wellness Clinic in Kennewick, we have seen Eastern Washington migraine patients who had reached exactly that point, and we want those patients to understand that IV ketamine is a therapeutic option worth exploring.
Understanding Migraine as a Neurological Condition
Migraine is not simply a severe headache. It is a complex neurological condition characterized by episodes of intense, often unilateral head pain accompanied by nausea, photophobia, phonophobia, and in some cases aura — transient neurological symptoms that precede the headache phase. The underlying biology involves cortical spreading depression, trigeminovascular activation, and neuroinflammatory cascades that are still being studied actively. Preventive medications — including beta-blockers, antiepileptics like topiramate, tricyclic antidepressants, and the newer CGRP monoclonal antibodies — aim to reduce attack frequency by modulating one or more of these pathways. Abortive treatments like triptans and ditans are designed to interrupt an attack in progress.
For patients whose migraines do not respond adequately to this standard toolkit, IV ketamine enters the picture as an off-label option. Ketamine’s relevance to migraine lies in part in its role as an NMDA receptor antagonist. The NMDA receptor is involved in central sensitization processes that contribute to migraine chronification — the transition from episodic to chronic migraine that many patients experience over years. By interrupting NMDA-mediated signaling, ketamine infusions may help interrupt the central sensitization cycle in patients with refractory chronic migraine. Several academic medical centers have published case series and small studies reporting meaningful reductions in migraine frequency and severity following ketamine infusion protocols, though this research is still developing and ketamine for migraine carries no FDA approval for this indication.
Our Clinical Team and Pre-Treatment Approach
At Tri-Cities Infusion and Wellness Clinic, every IV ketamine infusion — including those administered for migraine management — is delivered by a team that includes Tyler Thornock, ARNP, CRNA, Ben Clark, CRNA, Michelle Perez, NP, and Angela Shaw, NP. The clinical standards our team holds are drawn from formal anesthesia training: continuous monitoring, individualized dosing, and thorough pre-treatment review. Before any infusion, we conduct a health sync covering your migraine history, current preventive and abortive medications, prior treatment responses, and any comorbid conditions. This is important because migraine patients often arrive with complex medication histories that require careful review before proceeding.
We are aware that Eastern Washington migraine patients have historically faced meaningful barriers to specialized neurological care. Headache specialists and academic neurology centers are concentrated in larger urban centers, and for Kennewick, Richland, or Pasco residents dealing with monthly or weekly migraines, the idea of traveling to Spokane or Seattle to see a neurologist — often on a day when you are in the middle of an attack — is both logistically and physically difficult. We do not replace neurology consultation; we work as a complementary resource for migraine patients who are under a neurologist’s care or who want to integrate IV ketamine into a broader migraine management plan.
Common Patient Concerns About IV Ketamine for Migraine
One barrier we hear about is the concern that a ketamine infusion might trigger a migraine rather than treat one. This is a reasonable question, and it is one we address in the pre-treatment health sync. The evidence from clinical protocols at academic medical centers suggests that carefully dosed IV ketamine infusions are generally well-tolerated by migraine patients, and that the infusion itself does not typically trigger an attack in individuals with refractory migraine. That said, individual responses vary, and our monitoring protocol is designed to detect and respond to any adverse developments during the infusion. Results vary by individual, and patients should discuss with your provider what the expected experience looks like given their specific migraine pattern.
A second barrier is uncertainty about how ketamine for migraine fits with ongoing preventive treatment. We are not asking patients to abandon their current neurologist-directed regimen. IV ketamine is most appropriately positioned as a complementary intervention for patients who have not found adequate control through standard preventives — not as a replacement for them. We encourage patients to maintain open communication with their other providers so that care is coordinated rather than siloed. If you want to understand more about what preparing for this type of therapy looks like, our post on preparing for your first ketamine infusion walks through what to expect step by step. The goal is always to help you achieve better migraine control with a thoughtful, integrated approach.
For Eastern Washington residents who have been living with the profound disruption of chronic or refractory migraine, the availability of CRNA-administered IV ketamine therapy in Kennewick represents an option that may not have been accessible locally before. We are committed to providing that access with the same clinical rigor we bring to all of the conditions we treat.
Frequently Asked Questions
Does IV ketamine work for migraines?
IV ketamine is used off-label for refractory and chronic migraine. Some clinical series and small studies have reported reductions in migraine frequency and severity following ketamine infusion protocols. Results vary by individual, and we recommend discussing your specific migraine history with our team to understand whether you are a good candidate.
Is ketamine FDA-approved for migraine treatment?
No — IV ketamine is not FDA-approved for migraine. It is used off-label for this indication, guided by clinical judgment and emerging research. We are transparent about this in every consultation.
Will ketamine interact with my current migraine medications?
Ketamine can interact with various medications, and our pre-treatment health sync specifically covers all current preventive and abortive migraine medications before any infusion is scheduled. We review your full medication list before proceeding and flag any combinations that require additional clinical attention.
How quickly might I notice changes in my migraine pattern after IV ketamine?
Response timelines vary widely. Some patients notice changes in frequency or severity relatively quickly following an infusion series; others experience a more gradual shift over weeks. Results are not guaranteed and vary significantly by individual.
Can I receive IV ketamine for migraines alongside other treatments at your clinic?
Yes — one of the advantages of our Kennewick clinic is the range of integrated services we offer. IV wellness therapy and aesthetic services can complement clinical ketamine treatment as part of a comprehensive health approach, and we individualize every patient’s care plan accordingly.
Key Takeaways
- Chronic migraine is a disabling neurological condition affecting millions of Americans, and many patients do not achieve adequate control through standard preventive and abortive treatments.
- IV ketamine is used off-label for refractory migraine and may work by interrupting NMDA receptor-mediated central sensitization; it is not FDA-approved for this indication.
- All infusions at Tri-Cities Infusion and Wellness Clinic are administered by a clinical team that includes Tyler Thornock, ARNP, CRNA, Ben Clark, CRNA, Michelle Perez, NP, and Angela Shaw, NP, with individualized protocols and comprehensive pre-treatment health syncs.
- IV ketamine for migraine is best positioned as a complement to existing neurologist-directed care, not a replacement for it.
- Results vary by individual, and patients are encouraged to discuss with your provider whether IV ketamine fits their migraine history and treatment goals.
Conclusion
Refractory migraine deserves more than being told to try the next preventive on the list. For Eastern Washington patients who have reached that point, IV ketamine therapy at Tri-Cities Infusion and Wellness Clinic offers a neurologically distinct approach administered by a CRNA-trained team that takes your full clinical picture seriously. If chronic migraine is limiting your life and you want to explore all available options, we invite you to contact our Kennewick clinic and schedule a consultation about whether ketamine therapy might be a fit for your care.
About Our Providers
Tri-Cities Infusion and Wellness Clinic is led by Tyler Thornock, ARNP, CRNA, and Ben Clark, CRNA — certified registered nurse anesthetists who bring extensive backgrounds in anesthesia, IV pharmacology, and patient safety to every infusion they administer. Michelle Perez, NP, and Angela Shaw, NP, round out the clinical team, contributing to the individualized, patient-centered care that defines every visit at our Kennewick clinic. Together, our providers conduct thorough pre-treatment health syncs — reviewing medical history, current medications, and prior treatment responses — before proceeding with any care. The clinic specializes in ketamine infusion treatments for treatment-resistant depression and chronic pain conditions including CRPS, fibromyalgia, and neuropathy, with individualized protocols and insurance coverage through Asuris, Providence, Cigna, Premera, and others.
References
American Migraine Foundation — https://americanmigrainefoundation.org/resource-library/understanding-migraine/
National Institute of Neurological Disorders and Stroke — https://www.ninds.nih.gov/health-information/disorders/migraine
American Headache Society — https://americanheadachesociety.org/
National Institutes of Health / PubMed — https://pubmed.ncbi.nlm.nih.gov/30086289/
Medical Disclaimer
The content on this page is provided by Tri-Cities Infusion and Wellness Clinic for educational purposes only and does not constitute medical advice, diagnosis, or a treatment recommendation. IV ketamine is used off-label for migraine and is not FDA-approved for this indication. Results vary by individual, and not all migraine patients will experience benefit from ketamine therapy. Please discuss with your provider whether IV ketamine is appropriate for your specific migraine diagnosis, current medications, and treatment goals. Always consult a qualified healthcare professional before making decisions about your neurological or pain care.
